Immunophenotypic Characterization of Normal Blood CD56^+lo Versus CD56^+hi NK-Cell Subsets and Its Impact on the Understanding of Their Tissue Distribution and Functional Properties

By Lima M.   dos Anjos Teixeira M.   Queirós M.L.   Leite M.   Santos A.H.   Justiça B.   Orfão A.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 4, 2001-04 ,pp. : 731-743

Academic Press

Access to resources Recommend Favorite

CD38 as a prognostic marker in CLL

By MATRAI ZOLTAN  

Hematology, Vol. 10, Iss. 1, 2005-02 ,pp. : 39-46

Maney Publishing

Access to resources Recommend Favorite

Agranular CD4CD56 blastic natural killer leukemia/lymphoma

By Kimura Shinya   Kakazu Naoki   Kuroda Junya   Akaogi Teruaki   Hayashi Hideo   Nishida Kazuhiro   Abe Tatsuo  

Annals of Hematology, Vol. 80, Iss. 4, 2001-04 ,pp. : 228-231

Springer Publishing Company

Access to resources Recommend Favorite

Erythrocyte CD38 as a prognostic marker in cancer

By Albeniz Işil   Demir Özlem   Türker-Şener Leyla   Yalçintepe Leman   Nurten Rüstem   Bermek Engin  

Hematology, Vol. 12, Iss. 5, 2007-10 ,pp. : 409-414

Maney Publishing

Access to resources Recommend Favorite

The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression

By Balaian L.   Zhong R.-k.   Ball E.D.  

Experimental Hematology, Vol. 31, Iss. 5, 2003-05 ,pp. : 363-371

Elsevier

Access to resources Recommend Favorite